Danish Breast Cancer Cooperative Group

This trial was planned to compare a newer drug (trastuzumab deruxtecan) against standard treatments for a specific type of advanced breast cancer that has spread. It aimed to see which approach was better at controlling the disease and delaying its progression. However, the trial…